Purchase Order 75N95A24P00099

This firm-fixed-price purchase order was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the National Institutes of Health (NIH), to Psomagen Inc., a for-profit organization and manufacturer of goods. The $23,030 contract is for OLINK HT ANALYSIS services, which likely refers to genomic sequencing and analysis capabilities provided by Psomagen. The contract has an ultimate completion date of July 29, 2025 and was awarded on July 30, 2024 without any set-aside designation.

Psomagen Inc. is a subsidiary of Macrogen, Inc. and operates CLIA-certified and CAP-accredited facilities to provide a wide range of genomics and molecular biology services to federal agencies, particularly within the health and agricultural sectors. The company has established itself as a key provider of sequencing and omics services through various contract awards from NIH institutes and the U.S. Department of Agriculture. Psomagen also holds two significant federal contract Indefinite Delivery Vehicles (IDVs) - a $80,000 contract with USDA for Sanger sequencing services, and a $500 million contract with the NIH National Heart, Lung and Blood Institute to establish and operate the Centralized Omics Resource for the Trans-Omics for Precision Medicine (TOPMed) initiative.